Financial Gravity Asset Management, Inc. Kymera Therapeutics, Inc. Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	BUY	$22.9 - $43.57 $45 - $87	2 New	2 $67,000
Q1 2024 May 13, 2024	BUY	$22.9 - $43.57 $91 - $174	4 New	4 $152,000
Q4 2023 Jun 26, 2024	SELL	$10.97 - $26.84 $43 - $107	-4 Closed	0 $20,000
Q4 2023 Feb 15, 2024	BUY	$10.97 - $26.84 $0 - $0	0 New	0 $0
Q3 2023 Nov 15, 2023	SELL	$13.9 - $23.88 $319 - $549	-23 Closed	0 $0
Q2 2023 Aug 08, 2023	BUY	$22.4 - $34.92 $515 - $803	23 New	23 $49,000

181

64.3M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.21B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.